Search clinical trials for: Baseline Training

Total 11506 results

Pfizer

Completed

Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.

Colorectal Neoplasms

Australia, Canada, United States, New Zealand
Shanghai Zhongshan Hospital

Recruiting

The Consistency of Cardiac Output Measured by Pulmonary Artery Catheter and LiDCO in Cardiac Surgical Patients

Cardiac Surgery | Cardiac Output

China
Aalborg University Hospital
Aalborg University

Completed

Methods of Early Detection and Grading Of Diabetic Peripheral Neuropathy (MEDON) (MEDON)

Neuropathy, Diabetic | Neuropathy, Painful

Denmark
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer

Lung Cancer
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Terminated

Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by Surgery

Colorectal Cancer

United States
Servier Russia

Completed

Objective Confirmation of thе Anti-ischemic Effectiveness of Trimetazidine 80mg Once Daily in Patients With Stable Angina Who Had a History of Myocardial Infarction (METHOD) (METHOD)

Coronary Artery Disease

Russian Federation
City of Hope Medical Center

Active, not recruiting

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

Breast Cancer | Stage IV Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

Colorectal Cancer | Neoplasm of Uncertain Malignant Potential

United States
University Hospital Olomouc
Palacky University

Completed

Strip Meniscometry in Dry Eye Evaluation

Dry Eye | Dry Eye Disease

Czechia
Saint John's Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Studying Lymph Nodes in Patients With Stage II Colon Cancer

Colorectal Cancer

United States
University of California, Davis
Eli Lilly and Company

Completed

Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute
Cephalon, Inc.

Terminated

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia

United States
Borstkanker Onderzoek Groep
Roche Pharma AG; Teva Pharma

Completed

8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer (Stop&Go)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Netherlands
Hoffmann-La Roche

Completed

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)

Colorectal Cancer

United Kingdom
Texas Retina Associates

Completed

Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion

Non-Ischemic Central Retinal Vein Occlusion

United States
Colgate Palmolive

Completed

The Clinical Investigation of Toothpaste as Compared to Toothpaste and Mouthwash in Reducing Plaque and Gingivitis: A Six-week Clinical Study in the US

Gingivitis | Dental Plaque

United States
M.D. Anderson Cancer Center

Terminated

Multimodal Treatment Strategy for Cancer Cachexia

Cachexia | Advanced Cancer

United States
University of Southern California
Pfizer

Terminated

FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer

Colorectal Cancer

United States
Biogen
Elan Pharmaceuticals

Completed

Treatment Interruption of Natalizumab (RESTORE)

Relapsing Remitting Multiple Sclerosis

United States, Germany, Spain
National Cancer Institute (NCI)

Completed

Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab

Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Drug/Agent Toxicity by Tissue/Organ | Adenosquamous Cell Lung Cancer | Hemoptysis
European Organisation for Research and Treatment...

Unknown

Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

France
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult... and other conditions

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Leukemia

United States
Central Hospital, Nancy, France

Completed

Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C (PCA)

Septic Shock
University of Massachusetts, Worcester
National Cancer Institute (NCI)

Completed

Tobacco Treatment Medical Education in 10 Medical Schools (MSQuit)

Smoking Cessation | Tobacco Use Disorder

United States
Southern Italy Cooperative Oncology Group

Unknown

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

Italy
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Phase II Bevacizumab + Tax In Advanced Breast Cancer

Breast Cancer

United States
M.D. Anderson Cancer Center

Terminated

Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients

Ovarian Cancer

United States
Sanofi

Completed

Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer

Breast Neoplasms

United States
Jie Chen

Active, not recruiting

Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation

Nausea and Vomiting

China
The Greater Poland Cancer Centre

Active, not recruiting

Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy (SPORTNATHy)

Breast Cancer

Poland
Hoffmann-La Roche

Completed

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

Solid Tumor

United States, Korea, Republic of, Taiwan, Australia, Japan, New Zealand, China
Federation Francophone de Cancerologie Digestive

Completed

Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

France
Federation Francophone de Cancerologie Digestive

Completed

G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer

Colorectal Cancer
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

Breast Cancer

Italy
M.D. Anderson Cancer Center

Completed

Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

HAI Abraxane With Gemcitabine and Bevacizumab

Advanced Cancers

United States
National Cancer Institute (NCI)

Completed

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung Cancer

United States
Gruppo Oncologico del Nord-Ovest

Completed

Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (TRIBE)

Colorectal Cancer

Italy
Stony Brook University
National Institute of Mental Health (NIMH)

Completed

Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder

Conduct Disorder | Oppositional Defiant Disorder | Attention Deficit Disorder With Hyperactivity

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Colorectal Cancer

United States, Puerto Rico, South Africa
University of Tennessee Cancer Institute
Genentech, Inc.; Celgene Corporation; National Comprehensive Cancer Network

Unknown

Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen

Breast Cancer | Atrophic Vaginitis

United States
Aalborg University Hospital
University of Aarhus; Aalborg University

Recruiting

Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy (NeuroPredict)

Type 1 Diabetes | Neuropathy, Diabetic | Small Nerve Fiber Neuropathy

Denmark
University of Southern California
National Cancer Institute (NCI); California Breast Cancer Research Program

Completed

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Lobular Breast Carcinoma in Situ

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Kidney Cancer

United States
University of Southern California
National Cancer Institute (NCI); GlaxoSmithKline

Terminated

Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder

Recurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery

Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Melanoma (Skin)

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States

Search clinical trials for: Baseline Training

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations